top of page
Is Larotrectinib effective and safe for TRK fusion breast cancer?
In an interview, Dr. Agostinetto delves into the findings of Dr. Souza, who shares the results of his research explaining why larotrectinib is positioned as an effective and safe treatment option for patients with TRK fusion breast cancer.
Dr. Cristiano de Pádua Souza
Medical Oncologist - Hospital de Câncer de Barretos (Brazil)
Dr. Elisa Agostinetto
MD, Jules Bordet Institute, Brussels, Belgium
Sponsored by:
bottom of page